title: Intracardiac echo and reduced radiocontrast requirements during TAVR.
authors.forename: Thomas
authors.initials: T
authors.lastname: Bartel
authors.forename: Nikolaos
authors.initials: N
authors.lastname: Bonaros
authors.forename: Michael
authors.initials: M
authors.lastname: Edlinger
authors.forename: Corinna
authors.initials: C
authors.lastname: Velik-Salchner
authors.forename: Gudrun
authors.initials: G
authors.lastname: Feuchtner
authors.forename: Michael
authors.initials: M
authors.lastname: Rudnicki
authors.forename: Silvana
authors.initials: S
authors.lastname: Müller
mesh_terms: D058186:Acute Kidney Injury / Q000139:chemically induced / Q000517:prevention & control*; D001021:Aortic Valve / Q000000981:diagnostic imaging*; D006328:Cardiac Catheterization / Q000009:adverse effects; D003287:Contrast Media / Q000009:adverse effects; D006349:Heart Valve Diseases / Q000175:diagnosis / Q000628:therapy*; D019918:Heart Valve Prosthesis Implantation / Q000009:adverse effects / Q000379:methods*; D006801:Humans; D011237:Predictive Value of Tests; D015641:Radiography, Interventional / Q000009:adverse effects; D012307:Risk Factors; D013997:Time Factors; D016896:Treatment Outcome; D018084:Ultrasonography, Interventional / Q000009:adverse effects
chemical_list: D003287:Contrast Media